Asset Details
Do you wish to reserve the book?
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Do you wish to request the book?
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
2004
Overview
This double-blind trial involving 387 women with recurrent candidiasis evaluated the effectiveness of a regimen of 150 mg of oral fluconazole once per week. Six months after the completion of therapy, 90.8 percent of the women in the fluconazole group remained free of candidiasis, as compared with 35.9 percent in the placebo group.
This double-blind trial evaluated the effectiveness of a regimen of oral fluconazole once per week.
Since recurrent vulvovaginal candidiasis is estimated to occur in 5 to 8 percent of women during their reproductive years, millions of women worldwide are affected by the condition.
1
–
3
Not considered a typical sexually transmitted infection, recurrent vulvovaginal candidiasis affects immunocompetent, healthy women in all strata of society.
2
,
4
Although the condition has several causes, the majority of women with recurrent infection have no recognizable risk factors.
5
,
6
Frequent recurrences of symptomatic vulvovaginitis result in considerable suffering and cost and have a markedly negative effect on sexual relations.
7
Management approaches include treatment of each individual episode or use of prophylactic . . .
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Antifungal Agents - adverse effects
/ Antifungal Agents - therapeutic use
/ Biological and medical sciences
/ Candida albicans - isolation & purification
/ Candida glabrata - isolation & purification
/ Candidiasis, Vulvovaginal - drug therapy
/ Candidiasis, Vulvovaginal - prevention & control
/ Drug Administration Schedule
/ Female
/ Fluconazole - adverse effects
/ Fluconazole - therapeutic use
/ HIV
/ Human immunodeficiency virus
/ Humans
